Clinical Trial Update: A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results for CST-2032 and CST-107 in individuals with mild cognitive impairment or mild dementia due to Parkinson's or Al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia
• Parkinson Disease

Drugs mentioned

• CST-107
• CST-2032

Snippet

Sponsor: CuraSen Therapeutics, Inc. | Conditions: Mild Cognitive Impairment, Dementia | Phase 2 | Status: COMPLETED | Results posted: 2025-01-23